{"abstract":"The U.S. Nuclear Regulatory Commission (NRC) is issuing an order approving the license transfer application filed by SHINE Technologies, LLC, dated February 4, 2026, as supplemented on April 13, 2026. Specifically, the order approves the direct transfer of Construction Permit No. CPMIF-001 for the SHINE Medical Isotope Production Facility from SHINE Technologies, LLC to SHINE Chrysalis, LLC and a conforming license amendment. The order also approves the indirect transfer of control of the construction permit as a result of the establishment of SHINE Chrysalis Holdings, LLC as the direct parent company of SHINE Chrysalis, LLC. SHINE Chrysalis Holdings, LLC is a wholly owned subsidiary of Illuminated Holdings, Inc., the current parent company of SHINE Technologies, LLC.","action":"Order; issuance.","agencies":[{"raw_name":"NUCLEAR REGULATORY COMMISSION","name":"Nuclear Regulatory Commission","id":383,"url":"https://www.federalregister.gov/agencies/nuclear-regulatory-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/383","parent_id":null,"slug":"nuclear-regulatory-commission"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2026/04/30/2026-08415.html","cfr_references":[],"citation":"91 FR 23314","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The order was issued on April 22, 2026, and is effective for one year.","disposition_notes":null,"docket_ids":["Docket No. 50-608","NRC-2019-0029"],"dockets":[{"supporting_documents":[],"agency_name":"NRC","documents":[{"comment_count":null,"comment_start_date":null,"updated_at":"2026-04-30T11:04:30.867-04:00","comment_url":"https://www.regulations.gov/commenton/NRC-2019-0029-0005","allow_late_comments":false,"id":"NRC-2019-0029-0005","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"NRC-2019-0029","title":"SHINE Medical Isotope Production Facility;  Consideration of Approval of Transfer of License and Conforming Amendment"}],"document_number":"2026-08415","effective_on":null,"end_page":23315,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2026/04/30/2026-08415.xml","html_url":"https://www.federalregister.gov/documents/2026/04/30/2026-08415/in-the-matter-of-shine-technologies-llc-shine-medical-isotope-production-facility-direct-and","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2026-08415?publication_date=2026-04-30","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2026-04-30/2026-08415/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":124,"last_updated":"2026-06-19 20:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-30/pdf/2026-08415.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-08415.pdf?1777466714","publication_date":"2026-04-30","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2026/04/30/2026-08415.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_count":0,"agency_id":"NRC","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NRC-2019-0029","supporting_documents_count":0,"docket_id":"NRC-2019-0029","document_id":"NRC-2019-0029-0005","regulation_id_number":null,"title":"SHINE Medical Isotope Production Facility;  Consideration of Approval of Transfer of License and Conforming Amendment","checked_regulationsdotgov_at":"2026-05-01T11:55:04Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":23314,"subtype":null,"title":"In the Matter of SHINE Technologies, LLC; SHINE Medical Isotope Production Facility; Direct and Indirect Transfers of License","toc_doc":"SHINE Technologies, LLC;  SHINE Medical Isotope Production Facility","toc_subject":"Licenses; Exemptions, Applications, Amendments, etc.","topics":[],"type":"Notice","volume":91}